Level of the Ischemia-modified albumin (IMA) is higher in men with prostate cancer compared to healthy controls, and the levels are higher in men diagnosed with Gleason grade ≥7 cancers compared to those with Gleason grade < 7 cancers; and cases with Stage 2-4 disease compared to those recording Stage 1 prostate cancer [35,36]. This evidence concerns the gene ALB and prostate carcinoma.